FLEXI-GUIDE NEEDLE 15.5 GAUGE 9807GM15-5-20 9807GM15.5-20

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2009-03-20 for FLEXI-GUIDE NEEDLE 15.5 GAUGE 9807GM15-5-20 9807GM15.5-20 manufactured by Mick Radio-nuclear Instruments, Inc.

Event Text Entries

[1195347] Pt was administered an hdr prostate treatment using an afterloader attached to flexi-guide needles. The treatment called for 17 needles to be imbedded in the prostate, locked in place through a template grid and connected to the afterloader via fixed length transfer tubes. The needles accept a radioactive source wire driven out from the afterloader to administer a pre-planned dosage to the pt. Three treatment fractions were planned. Standard protocol called for the following: a dummy source wire is run through all transfer tubes in sequence into the respective needle to ensure no obstructions and to check for the proper length. After a successful dry run, the dummy wire is run through again to determine the proper depth. After this verification, the active source wire is run out and the dosage is administered. The needles were implanted according to plan and the first treatment fraction was administered on (b)(6)09 without incident. The needles remained in the pt overnight with a protective cone attached to protect the needles from becoming disturbed. The second fraction was administered in the morning of (b)(6)09. The dummy wire run for channels 1-17 was successfully completed and treatment commenced. Channels 1, 2 & 3 were completed without incident. Channel 4 was interrupted by a machine error message indicating the wire was too long for the channel. When the dummy wire was retracted there was blood present in the transfer tube. The physicist stopped treatment to call the manufacturer of the afterloader who assisted in planning the completion of the treatment. Treatment commenced for channels 5-17. Since the afterloader transfer tubes and source wire were contaminated with blood the final fraction scheduled for later the same day was aborted. When the needles were removed from the pt, it was discovered that the needle in channel 4 was missing the tip with allowed the blood to enter the system. The pt was subsequently sent home and is scheduled for the final treatment fraction on (b)(6)09.
Patient Sequence No: 1, Text Type: D, B5


[8145832] This is the first reportable incident involving the flexi-guide product.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2431392-2009-00001
MDR Report Key1387747
Report Source05
Date Received2009-03-20
Date Mfgr Received2009-03-13
Device Manufacturer Date2007-06-01
Date Added to Maude2010-02-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer Street521 HOMESTEAD AVE.
Manufacturer CityMOUNT VERNON NY 10550
Manufacturer CountryUS
Manufacturer Postal10550
Manufacturer Phone9146673999
Single Use3
Remedial ActionRL
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFLEXI-GUIDE NEEDLE 15.5 GAUGE
Generic NameHDR PROSTATE NEEDLE
Product CodeIWJ
Date Received2009-03-20
Returned To Mfg2009-03-20
Model Number9807GM15-5-20
Catalog Number9807GM15.5-20
Lot NumberM2007-093
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerMICK RADIO-NUCLEAR INSTRUMENTS, INC
Manufacturer Address521 HOMESTEAD AVE. MOUNT VERNON NY 10550 US 10550


Patients

Patient NumberTreatmentOutcomeDate
10 2009-03-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.